Longevity conference in Berkeley draws founders and researchers for health testing
The Vitalist Bay event held May 14 in Berkeley featured blood testing, workshops, and talks on aging. Organizers described the gathering as a shift from movement to industry.
abcnews.go.comOn May 14 for the second Vitalist Bay longevity conference. Participants sat under a lawn tent for a mass blood draw organized by Rythm Health, using at-home testing devices that collected samples from the upper arm. Robby Wade, CEO of Rythm Health, explained the heating-pad activation process before the draw. One attendee compared the testing setup to Theranos but noted that it worked.
Conference activities Talks covered cryopreservation and delaying menopause.
Optional sessions included a workshop on longevity therapeutics led by a co-founder of BioAge Labs, a Krav Maga lesson, and a sound bath. Adam Gries, co-founder of the conference and the larger Vitalist movement, asked in opening remarks whether society would continue to accept death as previous generations had.
Christine Peterson, co-founder of the Foresight Institute, said the longevity field is moving from a movement toward an industry. The event space also functions as a rationalist AI discussion hub and featured wicker furniture and rose bushes on its grounds.
Key Facts
Potential Impact
- 01
Additional companies may offer similar at-home biological-age testing at future events.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…